<DOC>
	<DOCNO>NCT01135927</DOCNO>
	<brief_summary>This trial conduct Japan . The aim clinical trial investigate effect NN1250 ( insulin degludec ) Japanese subject type 1 diabetes .</brief_summary>
	<brief_title>A Trial Investigating Effect NN1250 Japanese Subjects With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 1 diabetes mellitus ( diagnose clinically ) least 12 month Treated multiple daily insulin injection continuous subcutaneous insulin infusion ( CSII ) least 12 month Current daily basal insulin requirement equal 0.3 ( I ) U/kg/day Glycosylated haemoglobin A1c ( HbA1c ) equal 10.0 % ( one retest within week permit result last test conclusive ) Subject donate blood plasma past month 500 mL within 3 month prior screen Surgery trauma significant blood loss ( 500 mL ) within last 3 month prior screen Smoker ( define subject smoke 5 cigarette equivalent per day ) Not able willing refrain smoking use nicotine gum transdermal nicotine patch inpatient period ( clamp period )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>